En Rich Financial Partners LLC Exact Sciences Corp Transaction History
En Rich Financial Partners LLC
- $300 Billion
- Q4 2024
A detailed history of En Rich Financial Partners LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, En Rich Financial Partners LLC holds 328 shares of EXAS stock, worth $16,459. This represents 0.01% of its overall portfolio holdings.
Number of Shares
328
Previous 328
-0.0%
Holding current value
$16,459
Previous $22.4 Million
17.51%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$880 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$854 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$605 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$605 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$313 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.88B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...